Keith Killian

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Fatima Karzai, David James VanderWeele, Ravi A. Madan et al. · Journal for ImmunoTherapy of Cancer · 2018 · 312 citations · Full text

Medicine, Oncology, Pharmacology +17

A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors

Iacopo Petrini, Paul S. Meltzer, In‐Kyu Kim et al. · Nature Genetics · 2014 · 260 citations · Full text

Medicine, Genetics, Molecular Genetics +9

Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial

Ariel López-Chávez, Anish Thomas, Arun Rajan et al. · Journal of Clinical Oncology · 2015 · 235 citations

Medicine, Molecular Medicine, Oncology +17

Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization

Chibawanye Ene, Lincoln Edwards, Gregory Riddick et al. · PLoS ONE · 2012 · 108 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors

Iacopo Petrini, Paul S. Meltzer, Paolo Andrea Zucali et al. · Cell Death and Disease · 2012 · 101 citations · Full text

Life Sciences, Genetics, Oncology +17